ArticleFrontiers in oncology2022
Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical Cancer.
Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 25 citations in OpenAlex.
- Deep Learning and Machine Learning Algorithms for Cervical Cancer Segmentation on MRI: A Systematic Review.Journal of medical radiation sciences · 2026Review
- Artificial intelligence applications in adaptive radiotherapy-a narrative review.Translational cancer research · 2026Review
- Direct integration of deep learning-based GTV auto-segmentation into a clinical radiotherapy planning system.Physics and imaging in radiation oncology · 2026Article
- Multi-plane attention guided 3D nnU-Net for MRI-based cervical cancer segmentation.Frontiers in oncology · 2026Article
- Radiomics and artificial intelligence in precision radiotherapy for cervical cancer: a narrative review.Frontiers in oncology · 2026Review
- Domain-Adaptive and Per-Fraction Guided Deep Learning Framework for Magnetic Resonance Imaging-Based Segmentation of Organs at Risk in Gynecologic Cancers.Advances in radiation oncology · 2025Article
- AI-Guided Delineation of Gross Tumor Volume for Body Tumors: A Systematic Review.Diagnostics (Basel, Switzerland) · 2025Review
- Cer-ConvN3Unet: an end-to-end multi-parametric MRI-based pipeline for automated detection and segmentation of cervical cancer.European radiology experimental · 2025Article
- Feasibility study of U-Net-based automatic segmentation of pelvic bone marrow for postoperative radiotherapy in cervical cancer.Frontiers in oncology · 2025Article
- Comparison of Vendor-Pretrained and Custom-Trained Deep Learning Segmentation Models for Head-and-Neck, Breast, and Prostate Cancers.Diagnostics (Basel, Switzerland) · 2024Article
- Automatic segmentation of tumour and organs at risk in 3D MRI for cervical cancer radiation therapy with anatomical variations.Physical and engineering sciences in medicine · 2024Article
- Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancer.Physics and imaging in radiation oncology · 2024Article
- Deep Learning Framework with Multi-Head Dilated Encoders for Enhanced Segmentation of Cervical Cancer on Multiparametric Magnetic Resonance Imaging.Diagnostics (Basel, Switzerland) · 2023Article
- A Deep Learning Approach for Automatic Segmentation during Daily MRI-Linac Radiotherapy of Glioblastoma.Cancers · 2023Article
- Resection cavity auto-contouring for patients with pediatric medulloblastoma using only CT information.Journal of applied clinical medical physics · 2023Article
- Article
- Observational
- Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'?Diagnostics (Basel, Switzerland) · 2023Review
- Clinical evaluation on automatic segmentation results of convolutional neural networks in rectal cancer radiotherapy.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
Abstract
Background/Hypothesis: MRI-guided online adaptive radiotherapy (MRI-g-OART) improves target coverage and organs-at-risk (OARs) sparing in radiation therapy (RT). For patients with locally advanced cervical cancer (LACC) undergoing RT, changes in bladder and rectal filling contribute to large inter-fraction target volume motion. We hypothesized that deep learning (DL) convolutional neural networks (CNN) can be trained to accurately segment gross tumor volume (GTV) and OARs both in planning and daily fractions' MRI scans. Materials/Methods: We utilized planning and daily treatment fraction setup (RT-Fr) MRIs from LACC patients, treated with stereotactic body RT to a dose of 45-54 Gy in 25 fractions. Nine structures were manually contoured. MASK R-CNN network was trained and tested under three scenarios: Results: MRIs from fifteen LACC patients were analyzed. In the LOO scenario the DSC for Rectum, Femur, and Bladder was >0.8, followed by the GTV, Uterus, Mesorectum and Parametrium (0.6-0.7). The results for Vagina and Sigmoid were suboptimal. The performance of the network was similar for most organs when tested on RT-Fr MRI. Including the planning MRI in the training did not improve the segmentation of the RT-Fr MRI. There was a significant correlation between the average organ volume and the corresponding DSC (r = 0.759, p = 0.018). Conclusion: We have established a robust workflow for training MASK R-CNN to automatically segment GTV and OARs in MRI-g-OART of LACC. Albeit the small number of patients in this pilot project, the network was trained to successfully identify several structures while challenges remain, especially in relatively small organs. With the increase of the LACC cases, the performance of the network will improve. A robust auto-contouring tool would improve workflow efficiency and patient tolerance of the OART process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.